ÂÜÀòÂÒÂ×

Dr. Scott Jeffers joined GenSight as Chief Technical Officer in April 2022. Scott has extensive experience in senior executive chemistry, manufacturing, and control (CMC) development and operations roles in various biopharmaceutical and contract manufacturing companies such as, Redpin Therapeutics, uniQure, Selecta Biosciences, and Brammer Bio.

He has more than 20 years of experience in viral gene therapy, virology, biochemistry, and molecular biology. He is a recognized expert in the development and manufacture of gene therapy vectors for pre-clinical, clinical, and commercial-stage gene therapy drug products.

Based in Boston, USA, Scott is collaborating intensively with their manufacturing partners.

Scott completed two post-doctoral fellowships at the Pasteur Institute in Paris and the University of Colorado. He earned his Ph.D. in Virology at Purdue University and his B.S. in Biology at Colorado State University.